Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V, Fernández-Santana V, Hardy E, Toledo ME, Rodríguez MC, Heynngnezz L, Rodriguez A, Baly A, Herrera L, Izquierdo M, Villar A, Valdés Y, Cosme K, Deler ML, Montane M, Garcia E, Ramos A, Aguilar A, Medina E, Toraño G, Sosa I, Hernandez I, Martínez R, Muzachio A, Carmenates A, Costa L, Cardoso F, Campa C, Diaz M, Roy R. Verez-Bencomo V, et al. Science. 2004 Jul 23;305(5683):522-5. doi: 10.1126/science.1095209. Science. 2004. PMID: 15273395 Clinical Trial.
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
Fernández-Santana V, Cardoso F, Rodriguez A, Carmenate T, Peña L, Valdés Y, Hardy E, Mawas F, Heynngnezz L, Rodríguez MC, Figueroa I, Chang J, Toledo ME, Musacchio A, Hernández I, Izquierdo M, Cosme K, Roy R, Verez-Bencomo V. Fernández-Santana V, et al. Infect Immun. 2004 Dec;72(12):7115-23. doi: 10.1128/IAI.72.12.7115-7123.2004. Infect Immun. 2004. PMID: 15557635 Free PMC article.
Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.
Toraño G, Toledo ME, Baly A, Fernandez-Santana V, Rodriguez F, Alvarez Y, Serrano T, Musachio A, Hernandez I, Hardy E, Rodríguez A, Hernandez H, Aguilar A, Sánchez R, Diaz M, Muzio V, Dfana J, Rodríguez MC, Heynngnezz L, Verez-Bencomo V. Toraño G, et al. Clin Vaccine Immunol. 2006 Sep;13(9):1052-6. doi: 10.1128/CVI.00144-06. Clin Vaccine Immunol. 2006. PMID: 16960118 Free PMC article. Clinical Trial.
Glycoconjugate vaccines against Haemophilus influenzae type b.
Fernandez Santana V, Peña Icart L, Beurret M, Costa L, Verez Bencomo V. Fernandez Santana V, et al. Methods Enzymol. 2006;415:153-63. doi: 10.1016/S0076-6879(06)15010-7. Methods Enzymol. 2006. PMID: 17116473 No abstract available.
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: a randomized phase I clinical trial.
Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, Rosell S, González N, García-Rivera D, Valdés Y, Goldblatt D, Vérez-Bencomo V; Laboratory-Pneumococci Group; Havana-Pneumococci Group. Dotres CP, et al. Vaccine. 2014 Sep 15;32(41):5266-70. doi: 10.1016/j.vaccine.2014.06.094. Epub 2014 Jul 26. Vaccine. 2014. PMID: 25068497 Clinical Trial.
54 results